Zobrazeno 1 - 10
of 449
pro vyhledávání: '"M, van Ballegooijen"'
Publikováno v:
Cellular Oncology, Vol 29, Iss 3, Pp 185-194 (2007)
Colorectal carcinoma (CRC) is a common cancer and the second most common cause of death. The therapeutic costs for this disease will continue to rise due to an increasing incidence and the introduction of new chemotherapeutic modalities. Colorectal c
Externí odkaz:
https://doaj.org/article/fa023ab93acf46629d087b5d1feb0577
Autor:
M. de Visser, M. van Ballegooijen, S. M. Bloemers, S. J. H. van Deventer, J. B. M. J. Jansen, J. Jespersen, C. Kluft, G. A. Meijer, J. Stoker, G. A. de Valk, M. F. Verweij, F. A. Vlems
Publikováno v:
Cellular Oncology, Vol 27, Iss 1, Pp 17-29 (2005)
A consensus development meeting was held to evaluate whether or not in the Netherlands all requirements were fulfilled for implementation of population screening with FOBT for colorectal cancer, or whether consensus was present that fulfilment by add
Externí odkaz:
https://doaj.org/article/52225101b07f44dc9179f62a8cbb68ce
Autor:
Hajo Grundmann, Rolf J. F. Ypma, T. Bosch, Tjibbe Donker, A.P.J. Haenen, Jacco Wallinga, Leo M. Schouls, W. M. van Ballegooijen, Max Heck
Publikováno v:
The Journal of Hospital Infection
Journal of Hospital Infection, 93(4), 366-374. W B SAUNDERS CO LTD
Journal of Hospital Infection, 93(4), 366-374. W B SAUNDERS CO LTD
Background: In The Netherlands, efforts to control meticillin-resistant Staphylococcus aureus (MRSA) in hospitals have been largely successful due to stringent screening of patients on admission and isolation of those that fall into defined risk cate
Autor:
E B van Heijningen, Joel H. Rubenstein, John M. Inadomi, Sonja Kroep, M. van Ballegooijen, Iris Lansdorp-Vogelaar, Nuria Aragonés, Valery E.P.P. Lemmens
Publikováno v:
American Journal of Gastroenterology, 109(3), 336-343. Springer Nature
OBJECTIVES: The incidence of esophageal adenocarcinoma (EAC) in the western world has been rapidly increasing. The trends in obesity and other lifestyle-associated factors have been hypothesized to be important drivers of this increase. We tested thi
Autor:
Jacqueline C. Reijerink, L. van Dam, M E van Leerdam, Lieke Hol, Ida J. Korfage, M. van Ballegooijen, E. J. Kuipers, A H C van Roon
Publikováno v:
European Journal of Cancer, 49(10), 2321-2330. Elsevier Ltd.
Introduction Uptake is an important determinant of the effectiveness of population-based screening. Uptake of colorectal cancer (CRC) screening generally remains sub-optimal. Aim To determine factors influencing the decision whether to participate or
Autor:
Roderik A. Kraaijenhagen, Esther M. Stoop, M. van Ballegooijen, Evelien Dekker, Monique E. van Leerdam, Thomas R. de Wijkerslooth, Patrick M.M. Bossuyt, Ernst J. Kuipers, Paul Fockens, Inge Stegeman
Publikováno v:
International Journal of Cancer. 133:2408-2414
Differences in the risk of a false negative or a false positive fecal immunochemical test (FIT) across subgroups may affect optimal screening strategies. We evaluate whether subgroups are at increased risk of a false positive or a false negative FIT
Autor:
Paul Fockens, M. C. de Haan, E. Dekker, T. R. de Wijkerslooth, Ewout W. Steyerberg, L. van Dam, Patrick M.M. Bossuyt, Jaap Stoker, M. van Ballegooijen, E. J. Kuipers, Maarten Thomeer, M E van Leerdam, Esther M. Stoop
Publikováno v:
Endoscopy, 45(3), 182-188. Georg Thieme Verlag
Time limitations and unwanted health effects may act as barriers to participation in colorectal cancer (CRC) screening. The aim of the study was to measure the time requirements and health effects of colonoscopy and computed tomography colonography (
Autor:
Miguel A. Hernán, Michal F. Kaminski, E. Dekker, M. van Ballegooijen, Ann G. Zauber, E. J. Kuipers, Jaroslaw Regula, Michael Bretthauer, Kjetil Garborg, M E van Leerdam, Hans-Olov Adami, Tryggvi Stefansson, Lars Påhlman, Geir Hoff
Publikováno v:
Endoscopy, 44(7), 695-702. Georg Thieme Verlag
Background and study aim: While colonoscopy screening is widely used in several European countries and the United States, there are no randomized trials to quantify its benefits. The Nordic-European Initiative on Colorectal Cancer (NordICC) is a mult
Autor:
Marie-Louise Essink-Bot, M. van Ballegooijen, Ida J. Korfage, C. W. N. Looman, J. D. F. Habbema, B. Wauben
Publikováno v:
BJOG: An International Journal of Obstetrics & Gynaecology. 119:936-944
Please cite this paper as: Korfage I, van Ballegooijen M, Wauben B, Looman C, Habbema J, Essink-Bot M. Having a Pap smear, quality of life before and after cervical screening: a questionnaire study. BJOG 2012;119:936–944. Objective To assess the he
Publikováno v:
Bjog-An International Journal of Obstetrics and Gynaecology, 119(6), 699-709. Wiley-Blackwell Publishing Ltd
Please cite this paper as: van Rosmalen J, de Kok I, van Ballegooijen M. Cost-effectiveness of cervical cancer screening: cytology versus human papillomavirus DNA testing. BJOG 2012;119:699–709. Objective To determine the most cost-effective screen